Shengchun Wang

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Qian Zhang, Johnvesly Basappa, Hong Y Wang, Selene Nunez-Cruz, Cosimo Lobello, Shengchun Wang, Xiaobin Liu, Seble Chekol, Lili Guo, Amy Ziober, Reza Nejati, Alex Shestov, Michael Feldman, Jerry D Glickson, Suzanne D Turner, Ian A Blair, Chi Van Dang, Mariusz A Wasik
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function. Leukemia (2023)
Pin Lu, Shengchun Wang, Carrie A Franzen, Girish Venkataraman, Rebecca McClure, Lei Li, Wenjun Wu, Nifang Niu, Madina Sukhanova, Jianming Pei, Donald A Baldwin, Reza Nejati, Mariusz A Wasik, Nadia Khan, Yifan Tu, Juehua Gao, Yihua Chen, Shuo Ma, Richard A Larson, Y Lynn Wang
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood cancer journal 11 (2) (2021)

Shengchun Wang.css-eqlu8i{font-size:small;padding-left:4px;}